主页 / 药理学 / Ion Channels / Ligand-gated Ion Channels / Glutamate (Ionotropic) Receptors / Non-selective Ionotropic Glutamate / Non-selective Ionotropic Glutamate Antagonists / DL-AP4

DL-AP4

Cat. No. 0101 6 篇引用文献 提交评论 说明书 / 分析证书（CoA） / 化学品安全技术说明书（SDS）
Pricing Availability   Qty
说明： Broad spectrum glutamatergic antagonist
化学名： DL-2-Amino-4-phosphonobutyric acid
纯度： ≥98% (HPLC)
说明书
引用文献 (6)
评论
文献 (1)
生物活性 技术数据 溶解性 计算器 说明书 参考文献

生物活性 for DL-AP4

DL-AP4 is a broad spectrum EAA ligand.

D-isomer, L-isomer and Sodium Salt also available.

技术数据 for DL-AP4

分子量 183.1
公式 C4H10NO5P
储存 Store at RT
纯度 ≥98% (HPLC)
CAS Number 6323-99-5
PubChem ID 2207
InChI Key DDOQBQRIEWHWBT-UHFFFAOYSA-N
Smiles O=C(C(N)CCP(O)(O)=O)O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for DL-AP4

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
water 9.15 50

制备储备液 for DL-AP4

以下数据基于产品分子量 183.1。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
0.5 mM 10.92 mL 54.61 mL 109.23 mL
2.5 mM 2.18 mL 10.92 mL 21.85 mL
5 mM 1.09 mL 5.46 mL 10.92 mL
25 mM 0.22 mL 1.09 mL 2.18 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for DL-AP4

分析证书/产品说明书
选择另一批次：
化学品安全技术说明书

参考文献 for DL-AP4

参考文献是支持产品生物活性的出版物。

Evans et al (1979) Antagonism of excitatory amino acid-induced responses and of synaptic excitation in the isolated spinal cord of the frog. Br.J.Pharmacol. 67 591 PMID: 316343

Evans et al (1982) The effect of a series of ω-phosphonic-α-carboxylic amino acids on electrically evoked and amino acid induced responses in isolated spinal cord preparations. Br.J.Pharmacol. 75 65 PMID: 7042024

If you know of a relevant reference for DL-AP4, please let us know.

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Non-selective Ionotropic Glutamate Antagonists

关键词: DL-AP4, DL-AP4 supplier, Broad, spectrum, EAA, antagonists, Glutamate, Ionotropic, Non-Selective, iGluR, Receptors, mGlur, Metabotropic, 20263-07-4, Non-selective, mGlu, 0101, Tocris Bioscience

6 篇 DL-AP4 的引用文献

引用文献是使用了 Tocris 产品的出版物。 DL-AP4 的部分引用包括：

Ferlauto et al (2018) Design and validation of a foldable and photovoltaic wide-field epiretinal prosthesis. Nat Commun 9 992 PMID: 29520006

Chrispell et al (2018) Grk1b and Grk7a Both Contribute to the Recovery of the Isolated Cone Photoresponse in Larval Zebrafish. Invest Ophthalmol Vis Sci 59 5116 PMID: 30372740

Schmidt and Kofuji (2011) Structure and function of bistratified intrinsically photosensitive retinal ganglion cells in the mouse. J Comp Neurol 519 1492 PMID: 21452206

Schmidt and Kofuji (2009) Functional and morphological differences among intrinsically photosensitive retinal ganglion cells. J Neurosci 29 476 PMID: 19144848

您是否知道使用了 Tocris DL-AP4 的优秀论文？ 请告知我们.

DL-AP4 的评论

目前没有该产品的评论。 Be the first to review DL-AP4 and earn rewards!

Have you used DL-AP4?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意，Tocris 仅会向正规科研企业/机构地址发送文献。

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.